Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TNO
The Hague, Netherlandstno.nl ↗
- Ownership
- Private
- Employees
- ~3000
- Development stage
- Other
01
Overview
TNO accelerates preclinical and clinical research by providing advanced biological models, proprietary biomarker discovery approaches, and enabling technologies, supporting pharma and biotech companies to reach key drug development phases with increased accuracy and reduced cost. TNO has validated biomarkers for NASH and works on translational models for metabolic and cardiovascular diseases[2][10].
- Therapeutic areas
- ImmunologyCardiovascularEndocrinologyRheumatologyGastroenterologyInfectious DiseasesMetabolic Disorders
- Modalities
- Small moleculeBiologicAntibodyBiomarkerDevice
- Industry
- Academic Hospital/University/Research
02
Partnerships
GalapagosDutch government (multiple programs)
Beyond the preview
Go deeper on TNO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TNO.